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Mouse Eotaxin Expression Parallels Eosinophil
Accumulation during Lung Allergic Inflammation
but It Is Not Restricted to a Th2-Type Response
J.-A. Gonzalo,1, 6 G-Q. Jia,1, 6 initial rolling on inflamed vascular endothelium via selec-
V. Aguirre,1 D. Friend,2 A. J. Coyle,5 tin interaction with carbohydrate ligands or a4 integrins;
N. A. Jenkins,4 G-S. Lin,1 H. Katz,2 second, activation by chemokines or other chemoat-
A. Lichtman,3 N. Copeland,4 M. Kopf,5 tractants; third, firmattachment to theblood vessel walls
and J.-C. Gutierrez-Ramos1 mediated by interactions between integrins and their
1The Center for Blood Research, Incorporated ligands; and finally, transendothelial migration (Butcher,
and Department of Genetics 1991; Lasky, 1992; Springer, 1994). Eosinophils, as well
Harvard Medical School as other leukocytes, use various pathways to bind endo-
2Division of Rheumatology, thelial cells, including expression of the cell adhesion
3 Immunology and Pathology molecules ICAM-1, ICAM-2, E-selectin, and P-selectin
Brigham and Women's Hospital (Resnick and Weller, 1993). As the only granulocyte that
Boston, Massachusetts 02115 expresses VLA-4, eosinophils may selectively bind to
4Mammalian Genetics Laboratory endothelial cells, in vivo, via VCAM-1 (Weller et al., 1991).
National Cancer Institute Various chemoattractants found to be active on eosino-
Frederick Cancer Research and Development Center phils, such as leukotriene B4 and platelet-derived
Frederick, Maryland 21702 growth factor (Baggiolini et al., 1994), have been identi-
5Basel Institute for Immunology fied. Among chemokines, several members of the C±C
Basel family have been shown to support a moderate migra-
Switzerland tion of human eosinophils in vitro (Dahinden et al., 1994;
Rot et al., 1992). However, none of these molecules are
eosinophil specific and their role in the pathogenesis
Summary of an in vivo experimental animal model has not been
addressed. Recently, a novel member of the C±C che-
A model of lung eosinophilia based on the repeated mokine family with specific action on guinea pig eosino-
exposure of mice to aerosolized OVA has been used phils has been identified and cloned (Jose et al., 1994a,
to identify C±C chemokine genes expressed at stages 1994b). The mRNA expression of this chemokine, Eo-
of massive eosinophil infiltration. We describe the
taxin, has been shown to be induced in a guinea pig
identification and cloning of a cDNA that encodes a
model of allergic airways inflammation (Rothenberg et
mouse C±C chemokine with 68% amino acid identity
al., 1995a).to guinea pig Eotaxin. The recombinant protein en-
Critical events mediating allergic reactions and hel-coded by this gene displays potent and specific che-
minthic parasitic infections in humans and mice are reg-motactic activity for eosinophils, both in vivo and in
ulated by the development of a so-called T helper 2 (Th2)vitro. Its mRNA levels parallel the kinetics of eosinophil
response characterized by the production of specificaccumulation in the lung during the experimentally
cytokines, particularly interleukin-4 (IL-4) and IL-5 (Dur-induced eosinophilia and it is mainly produced by type
ham et al., 1992; Mossmann et al., 1986; Wierenga et al.,I alveolar epithelial cells. The mRNA expression of
1990). IL-4 is of critical importance for immunoglobulin Emouse Eotaxin is not restricted to Th2 T cells in vitro
(IgE) production and its action enhances the endothelialand is independent of the development of a Th2-type
expression of VCAM-1, which is required for the selec-response during N. brasiliensis infection, in vivo.
tive adhesion of eosinophils (Briscoe et al., 1992; Del
Prete et al., 1988; Schleimeret al.,1992). IL-5 specificallyIntroduction
regulates eosinophil growth and differentiation (Lopez
et al., 1986), and its overexpression in transgenic miceThe accumulation of eosinophilic leukocytes is a feature
induces blood eosinophilia. However, it does not resultof inflammatory reactions that occur in allergic asthma,
in eosinophil tissue accumulation or organ damageallergic rhinitis, and eczema (De Monchy et al., 1985).
(Dent et al., 1990). How eosinophil-specific chemoat-The magnitude of both acute and chronic asthmatic
tractants are regulated in a Th2 response is not known.reactions correlates with the number of eosinophils
The aim of this work was to identify C±C chemokinespresent in the lung (Bradley et al., 1991) and suppression
of this eosinophil accumulation impairs the development involved in the in vivo recruitment of eosinophils in mice.
and progression of these processes (Wegner et al., This approach would allow the study of their role and
1990). The mechanisms governingeosinophil extravasa- regulation in well-characterized wild-type and mutant
tion, tissue homing, and recruitment inasthma and other mouse strains that are well defined immunologically and
specific diseases, such as helminthic parasitic infec- developmentally. Here, we report that the development
tions, presumably follow the same steps that have been of a mouse model of lung eosinophilia based on the
hypothesized for the emigration of other leukocyte sub- exposure of sensitized mice to aerosolized antigen; sec-
sets from the circulation into surrounding tissues. These ond, the isolation of a cDNA from these hypereosinophi-
sequential events have been described as follows: first, lic lungs by polymerase chain reaction (PCR) amplifica-
tion based on consensus sequences present in C±C
chemokine genes; third, the comparison of this mouse6 These authors contributed equally to this work.
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Figure 1. Pulmonary Eosinophil Infiltration
Induced by OVA Treatment
(A) Eosinophil infiltration at 0, 1, 3, 6, or 12 hr
after OVA administration on days 15, 18, or
21 of OVA treatment in lung sections (dots)
and in BAL fluid (bars). Closed circles and
open circles represent the number of eosino-
phils counted in lung sections of experimen-
tal and control mice, respectively. Error bars
indicate thestandard deviation of the average
of eosinophils counted in four high power
fields per lung in four experiments with five
OVA-treated mice per experiment. Totalnum-
ber of eosinophils in the BAL fluid (repre-
sented as a bar diagram) was calculated as
the product of the total cellularity of the BAL
and the fraction of eosinophils in each sam-
ple. Values in the figure result from the sub-
traction of the absolute number of eosino-
phils found in PBS-treated controls from the
number found in OVA-treated mice. A sche-
matic representation of the OVA treatment is
shown at the bottom of the graph.
(B) H and E staining of lung sections from
OVA-treated mice on day 21 of treatment (3
hr after final OVA inhalation). The figure shows
perivascular, peribronchiolar, and alveolar in-
filtrates containing numerous eosinophils.
sequence with those of closely related mouse and hu- lung sections or by determining the number of eosino-
phils present in bronchoalveolar lavage (BAL) (Figureman members of the C±C chemokine family; fourth, the
1A). At all timepoints analyzed on day 15 of treatment,activity of the protein encoded by this gene in in vitro
no significant increase of pulmonary eosinophil infiltra-chemotaxis assays as well as after in vivo administra-
tion in OVA-treated mice over that found in phosphate-tion; and fifth, the regulation of the expression of this
buffered saline (PBS)-treated mice was detected. How-gene during Nippostrogylus brasiliensis infection and
ever, on days 18 and 21 of treatment, an increase induring a Th1/Th2 switch response.
infiltrating eosinophils, which peaks after 3 hr at 4-fold
and 9-fold on days 18 and 21, respectively, was detect-
Results able within 1 hr of the final OVA administration. The
analysis of mice 3 hr after OVA administration on day
Kinetics of Eosinophil Accumulation in the 21 of treatment showed thegreatest eosinophil accumu-
Mouse Lung in Response to Ovalbumin lation, seen as large perivascular, peribronchiolar, and
Airway inflammation and eosinophilia induced in guinea alveolar infiltrates (Figure 1B). After 3 hr and until at least
pigs and mice by sensitization and repeated challenge 12 hr after OVA challenge, a reduction in the number
with ovalbumin (OVA) is a well-established model used of infiltrating eosinophils was observed. Despite this
by a number of investigators (Jose et al., 1994b; Naka- reduction, the increase in infiltrating eosinophils is ap-
jima et al., 1994; Rothenberg et al., 1995a). To character- proximately 2-fold at 6 and 12 hr on day 18 and 4-fold
ize murine lung eosinophilia, mice were sensitized with on day 21 when compared with PBS-treated mice.
a single intraperitoneal injection of OVA followed by re- The number of eosinophils is increased in the BAL
peated aerosolized exposure. On days 15, 18, and 21 fluid of OVA-treated mice (Figure 1A). This increase also
of treatment (Figure 1A), pulmonary eosinophil infiltra- reaches a maximum 3 hr after treatment on day 21 (17-
tion at 0, 1, 3, 6, and 12 hr after exposure to the last dose to 20-fold increase). The kinetics of eosinophil accumu-
lation in the BAL fluid parallels that of infiltration intoof OVA was evaluated either by counting eosinophils in
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the lungs except that on days 18 and 21, by 12 hr after
OVA inhalation, the number of eosinophils present in
the BAL fluid of OVA-treated mice decreases to basal
levels (Figure 1A; data not shown).
Cloning, Mapping, and Structural Analysis
of Mouse Eotaxin
PCR primers were designed from the most conserved
regions in the C±C chemokine gene family to enable
the specific amplification of RNAs derived from related
genes. These primers were used in a PCR with cDNA
derived from lung RNA of OVA-treated mice (day 21,
3 hr after challenge). PCR products were cloned (32
independent clones were generated), sequenced, and
classified into three different groups. The most numer-
ous group contained 16 clones with highest homology
to guinea pig Eotaxin (gpEot) (71%) (Griffith-Johnson et
al., 1993), lower homology to hMCP-3 (53%) (Minty et
al., 1993), and even lower homology when compared
with other mouse C±C chemokines such as mMCP-1/
JE (51%), mRANTES (40%), and mMARC (35.5%). This
partial cDNA clone was thus a good candidate for a
partial cDNA of the mouse Eotaxin (mEot) gene. The
Figure 2. Nucleotide Sequence and Comparison of the Amino Acidrapid amplification of cDNA ends (RACE) cloning strat-
Sequence of the mEot Geneegy (Frohman et al., 1988) was employed to isolate the
(A) Nucleotide sequence of the mEot cDNA. Sequence outlined infull-length cDNA encoding mEot as described in Experi-
a 3 nt frame is the coding sequence. Overlined sequence denotes
mental Procedures. In brief, one specific primer was primers used for RT±PCR. Underlined sequence is the fragment of
designed based on the known sequence of the 150 bp the cDNA used as a probe for Northern blots, Southern blots, and
cDNA fragment obtained above. This primer, together ISH studies. The polyadenylation site is bold and underlined. The
boxes enclose the ATTTA sequences that has been reported towith a (dT)17-T7 primer employed as an adaptor, were
decrease mRNA stability. The mouse eotaxin sequence has beenused for the 59 end RACE. Sequence analysis of PCR
deposited in the GeneBank data base (accession number: U40672).products obtained in the previous step revealed that the
(B) Amino acid sequence alignment of C±C chemokines. Proteinamplified product is a peptide with the characteristics
sequences of hEot (Ponath et al., 1995), gpEot (Griffith-Johnson et
of and high homology to gpEot, and allowed the design al., 1993), hMCP-3 (Minty et al., 1993), hMCP-1 (Li et al., 1993),
of more specific nested primers, which could be used mRANTES (Neilson et al., 1992), mJE (Kawahara and Deuel, 1989)
were compared with the predicted sequence of mEot. Boxed resi-for the 39 end RACE cloning of the full-length mEot
dues indicate the four cysteine residues characteristic of the C±CcDNA. After two rounds of nested amplification, a single
chemokine family. Shaded boxed residues represent conserved re-PCR product of approximately 1 kb was cloned and
gions in the proposed Eotaxin subfamily. The potential N-glycosyla-sequenced. This PCR product contained the regions of
tion site on hMCP-3 is indicated by an asterisk. The putative cleav-
sequence previously found both in the 150 bp fragment age site of the signal peptides is indicated by an arrow.
obtained in the primary PCR as well as the 290 bp frag-
ment obtained in the 59 RACE experiments. This clone
was designated clone 28.
preparation of this manuscript, another group has inde-The whole cDNA corresponding to clone 28 contains
pendently cloned a mouse homolog to the gpEot gene,980 bp (Figure 2A) whose nucleotide sequence was con-
which has identical sequence to the cDNA reported herefirmed by three independent PCR amplifications. Analy-
(Rothenberg et al., 1995b).sis of its sequence revealed an open reading frame of
The comparison of amino acid sequence of the mEot341 bases encoding a protein of 97 aa, a 59 untranslated
gene with other members of the C±C chemokine familyregion of 47 bp, and a 39 untranslated region of 630 bp
as well as with gp and human Eotaxin (Ponath et al.,(Figure 2A). In the 39 untranslated region, one polyade-
1996) (Figure 2B) revealed the conservation of the four-nylation signal and several ATTTAtranscript destabiliza-
cysteine motif present in these chemokines and that thetion motifs (Shaw and Kamen, 1986) are found. No po-
first two cysteine residues are adjacent (Oppenheim ettential N-glycosylation sites are present in this protein.
al., 1991). mEot is characterized by the presence of aThe cDNA sequence showed significant homology to
two-residue gap located before the second proline ofother members of the C±C chemokine family, especially
the putative mature protein and a highly conserved do-to members of the MCP family and gpEot. The nucleo-
main (ICADPKKKWVQD; Figure 2B, shaded box). Com-tide sequence encoded by this mouse gene is 78% iden-
parison of the predicted amino acid sequence of mEottical to gpEot, 73% equal to hMCP-3, and 66% equal to
with other members of this family revealed a high degreemMCP-1 (Table 1). Based on its high nucleotide identity
of identity to hEot (58%), gpEot (63%), hMCP-3 (57%),with the gpEot gene and other features described below,
hMCP-1 (52%), mMCP-1 (49%), and mRANTES (37%)this mouse C±C chemokine gene will be identified during
the rest of this report as mEot. In addition, during the (Table 1).
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Table 1. C-C Chemokine Comparison with mouse Eotaxin
%% Amino Acid
Nucleotide
Chemokine Identity Similarity Identity
gp Eot 63.5 68.7 78.0
h Eot 58.7 71.1
h MCP-1 52.6 63.9 69.7
h MCP-2 58.8 68.0
h MCP-3 57.3 67.7 72.7
m JE 49.5 63.9 66.5
m MARC 46.4 61.8 67.4
h RANTES 34.4 51.1 58.1
m RANTES 37.8 52.2 55.5
h MIP1a 35.5 53.3 59.7
h MIP1b 36.7 53.3 61.2
m MIP1a 35.9 52.8 59.4
m MIP1b 34.4 52.1 60.9
The mouse chromosomal location of eotaxin (desig-
nated gene symbol Scya11 for small inducible cytokine
a11) was determinedby interspecific backcross analysis
using progeny derived from matings of ([C57BL/6J 3
M. spretus]F1 3 C57BL/6J)mice (Copeland and Jenkins,
1991). The mapping results indicated that Scya11 is lo-
cated in the central region of mouse chromosome 11
(data not shown).
To determine the possible existence of a gene homol-
ogous to mEot in other species, a Southern blot with
human, bovine, rat, Xenopus laevis, Caenorhabditis
elegans, and zebra fish genomic DNA was hybridized
using the mEot probe. Under conditions of high strin-
gency, a single hybridizing band was detected only in
Figure 3. Functional Activity of the mEot Recombinant Proteinmouse, human, bovine, and rat genomic DNAs, sug-
(A) Migration of purified eosinophils to supernatant containing mEotgesting that a single gene encodes for Eotaxin or its
recombinant protein (open bars) or to bacterial rmEot (100 ng/ml
homologs in these species (data not shown). and 500 ng/ml; stippled bars). Supernatant from cells transfected
with the antisense mEot gene (closed bars) or cell culture media
(shaded bars) were used as controls.In Vitro and In Vivo Chemotactic Activities
(B) Migration of other leukocyte subsets to mEot. Positive controlsof mEot Protein on Leukocytes
used for these experiments were rmMCP-1, rhMIP-1a, and rhIL-8,
To evaluate the functional chemotactic properties of which elicited chemotactic indexes ranging from 10%±60% de-
the protein encoded by this mouse chemokine cDNA, pending on the leukocyte subset and chemokine (data not shown).
recombinant protein was generated by cloning the mEot Concentrations or dilutions of supernatants not tested are indicated
with an asterisk. Migration is expressed as the percentage of theinto the expression vector pEFpuro in both orientations
total number of input leukocyte of each subtype that migrated towith respect to the promoter (Mizushima and Nagata,
the lower chamber.1990). X63/0 myeloma cells were then transfected with
(C) mEot recombinant protein-induced peritoneal eosinophil accu-pEF-mEOT plasmid carrying either the sense or anti-
mulation. Peritoneal exudate was collected at the timepoints indi-
sense mEot cDNA. Transfectants were selected and cated from C57BL/6J mice previously injectedwith mEot-containing
expanded and experimental as well as control tissue tissue culture supernatant (closed squares and circles) or control
supernatant (open symbols). Two different doses of mEot proteinculture supernatants obtained, as described in Experi-
were used (12.5 U in a volume of 100 ml, closed circles; or 62.5 Umental Procedures. Recombinant mEot protein was also
in a volume of 500 ml, closed squares). hMCP-1 was administeredobtained from a bacterial expression system and puri-
as a negative control of eosinophil accumulation (closed triangles).
fied by high pressure liquid chromatography (HPLC) or The number of eosinophils in the peritonealexudate was determined
ion/exchange (see Experimental Procedures). as described in Experimental Procedures. The error bars represent
Eosinophil chemotaxis was evaluated using purified differences between the values obtained in three independent ex-
periments (3 mice per experiment and timepoint).mouse eosinophils (80%±95% pure) obtained from the
blood of IL-5 transgenic mice (Tominaga et al., 1991).
Supernatant containing mEot recombinant protein or
HPLC-purified bacterial recombinant mEot protein (bac- In parallel assays with control supernatant or control
protein, only 2% of input cells migrated and the percent-terial rmEot), chemoattracted eosinophils, but not lym-
phocytes, macrophages, or neutrophils (Figures 3A, 3B). age of eosinophil was unchanged compared with the
input population (Figure 3A). To evaluate the chemotac-mEot protein attracted 80%±98% of the input cells and
the percentage of eosinophils increased from 85%±90% tic function of mEot recombinant protein on lympho-
cytes, neutrophils, and monocytes, these freshly iso-in the input population to 95%±99% in the migratory
cell population in a dose-dependent manner (Figure 3A). lated population were used for in vitro chemotaxis
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assays performed as described above. Several separate To determine whether direct administration of mEot
experiments with purified or enriched populations recombinant protein into the lung of unmanipulated
showed no significant differences in total number of mice causes accumulation of eosinophils in the BAL,
migratory cells or in the percentageof any specific popu- we delivered mEot protein into lung of anesthetized
lation (lymphocytes, neutrophils, or monocytes) be- mice. Mice were kept under anesthesia for 0, 1, 2, or 3
tween mEot and control supernatants (Figures 3A, 3B; hr after the administration of mEot recombinant protein
data not shown). to allow the normal recirculation of leukocytes. After
To determine whether the mEot recombinant protein each timepoint, mice were euthanized and BAL was
recruits eosinophils in vivo, leukocytes were quantitated performed. Recruitment of eosinophils into the BAL fluid
in the peritoneal exudates of mice 0, 1, 2, 3, or 4 hr after of mEot-injected mice was observed. Accumulation in
injection with tissue culture supernatant carrying the comparison to mice administered a similar volume of
mEot recombinant protein. Mice injected with mEot re- control supernatant is given in Table 2.
combinant protein showed an increase in the total num-
ber of cells recovered from the peritoneal exudates, In Vivo Analysis of mEot mRNA Expression
whichmaximizes2 hraftermEot protein injection (2.6 3 106 during Pulmonary Eosinophilia
6 0.5 3 106 cells/mouse) in comparison with the number We next determined whether mEot mRNA expression
of cells recovered from the peritoneum of mice injected during the course of the OVA treatment correlates with
with a similar volume of PBS (1.5 3 106 6 0.1 3 106 the degree of eosinophilia in the lung (see Figure 1A)
cells/mouse). Cells from the exudates were cytospun by Northern blot analysis. mEot mRNA expression is
onto glass slides, stained with Wright±Giemsa, and ex-
detectable in the lung of OVA-treated (n 5 2 per time-
amined microscopically for cell lineage identification.
point) but not PBS-treated control mice (n 5 7) and
No significant increases in total number of macrophages
repeated exposure to aerosolized OVA results in the
or lymphocytes were detected in the peritoneal exu-
progressive increase of mEot mRNA expression (Figure
dates after mEot or control supernatant injection. In
4A). The increase in mEot mRNA is approximately 12-
contrast, the absolute number or neutrophils increased
fold and 5-fold onday 21 compared with the levels found
from 12 3 104 6 2 3 104 cells/mouse in untreated mice
on day 15 and day 18, respectively.
to 65 3 104 6 5 3 104 cells/mouse in either mEot or
The kinetics of mEot mRNA expression on day 21 ofcontrol injected mice. However, as soon as 1 hr after
treatment at different timepoints after OVA challengemEot recombinant protein administration, there was a
was studied by reverse transcription and PCR (RT±PCR;mEot-specific increase in the number of eosinophils
Figure 4B). These experiments demonstrate that mEot(Figure 3C), which was not seen in control supernatant-
mRNA levels parallel the number of eosinophils foundinjected mice. As with the total number of cells, the
in the lung and BAL of OVA-treated mice (see Figuremaximum accumulation of eosinophils in the perito-
1A; Figure 4B).neum occurred 2 hr after mEot recombinant protein in-
To determine the cell type(s) producing mEot mRNAjection. Eosinophils increased from 1%±2% of the total
in the lung at the time of maximum eosinophilia (day 21,cells in the exudate of untreated mice to 20%±30% in
3 hr), we performed whole-mount in situ mRNA hybrid-mEot-treated mice (the percentage of eosinophils in
ization (ISH) in lungs from OVA- and PBS-treated micecontrol supernatant-injected mice remained unaf-
(Figures 4C, 4D). Adult lungs excised from PBS-treatedfected). At 1, 2, 3, and 4 hr after a single injection of
control C57BL/6J mice showed no specific alkaline12.5 U of recombinant mEot protein, 4-, 14-, 8- and 5-fold
phosphatase±generated blue staining on whole-mountincreases in eosinophils were found in comparison to
observation under darkfield illumination (Figure 4C,mice injected with control supernatant, respectively.
panel I) nor after paraffin embedding, sectioning, andWhen a larger dose (62.5 U) of mEot recombinant protein
counterstaining indicating the absence of mEot mRNAwas injected, an approximately 30-fold increase in the
(Figure 4D, panel I), as detectable by this system. Lungsnumber of eosinophils was found 2 hr after injection
from OVA-treated littermates exhibit intense staining(Figure 3C). The intraperitoneal injection of identical vol-
(Figure 4C, panel II) on whole-mount observation in aumes of neither control supernatant nor different doses
pattern that outlines individual alveoli and surroundsof hMCP-1 induced peritoneal eosinophil accumulation
small bronchi (Figure 4C, panel II). Upon sectioning,at any timepoints (Figure 3C). The ability of mEot to
specific mEot mRNA was detected as positive stainingrecruit eosinophils to the peritoneum has been con-
characterized by a granular blue precipitate within thefirmed using HPLC-purified bacterial rmEot protein, al-
thinned out cytoplasm of flattened cells lining the alveolithough in these experiments neutrophil number did not
increase (data not shown). (Figure 4D, panel II), which was not detected either in
Table 2. Eotaxin-induced eosinophil recruitment in BAL fluid
Time(h) after Number of eosinophils fold over
injection (x1023) control
Control mEot
Experiment 1 0 10.7 6 5.5 7.7 6 2.2 0.7
Experiment 2 1 13.8 6 3.9 57.1 6 4.2 4.1
Experiment 3 2 2.2 6 1.3 42.3 6 2.8 19.2
Experiment 4 3 9.1 6 4.1 46.4 6 5.3 5.1
Numbers of eosinophils counted in BAL fluid at different time points after administration of mEot (12.5 U/100 ml) or control protein.
Immunity
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Figure 4. mEot mRNA Expression in the Lung during OVA Treatment
(A) Northern blot of mEot mRNA expression during OVA treatment. On the indicated days, total RNA from the lung of experimental mice was
extracted 3 hr after OVA administration. Analysis showed one single hybridization band of z0.9 kb. In the lower panel, a control hybridization
with the b-actin gene is shown. Total RNA from lungs of untreated mice was also used in the same blot (data not shown).
(B) RT±PCR of mEot mRNA expression on day 21 of OVA treatment. Total RNA was extracted from the lung of experimental mice 0, 1, 3, and
6 hr after OVA administration on day 21. After RT, equal aliquots of cDNA were amplified with either mEot-specific primers (top) or b-actin
primers (bottom). RNA from the lung of untreated mice was also analyzed (data not shown).
(C) Darkfield view of a lung excised from a PBS-treated mouse subjected to whole-mount ISH with an antisense mEot-labeled riboprobe
(panel I). Note that even under darkfield filter, no specific alkaline phosphatase±generated blue stain is evident in the PBS-treated controls.
A photograph, viewed under transilumination, of a lung excised from an OVA-treated mouse on day 21, 3 hr after final treatment subjected
to ISH with an antisense mEot riboprobe. Note specific signal outlining individual alveoli (white arrows in panel II).
(D) Oil immersion view of a section from a lung treated as that in (C), panel I followed by paraffin-embedding and sectioning (panel I). Brown
color evident in the large alveolus in the center of the picture is not specific signal, but simply a thick area of tissue. Oil immersion view of a
section from a lung treated as that in (C) (panel II). Note specific staining along the flattened cytoplasm of the type I alveolar epithelial cells
(arrows).
the PBS-treated controls (Figure 4D, panel I) or in the To determine whether mast cells express mEot
mRNA, total RNA was isolated from mouse IL-3-depen-lung of OVA-treated mice hybridized with the sense
probe control (data not shown; see Experimental Proce- dent bone marrow culture-derived mast cells and a vec-
tor-control transfectant derived from the MC4W mousedures for details). This pattern is consistent with staining
of type I alveolar epithelial cells (Cotran et al., 1994). mast cell line. RNA was also isolated from the cells 1
hr after they had been activated with IgE and antigen
or sensitized with IgE but not activated. No mEot tran-Regulation of mEot mRNA Expression
in Different Organs and Cell Lineages scripts were detected in the mast cell populations by
Northern blot analysis of 10 mg total RNA or by RT±PCRTo examine the tissue distribution of mEot mRNA, North-
ern blots were performed with total RNA from different analyses (data not shown).
To study mEot expression during an inflammatory re-organs and hybridized with an mEot-specific probe that
hybridizes with a 0.9 kb transcript. To confirm the RNA sponse, Northern blots containing RNA from organs ex-
cised from mice injected with lipopolysaccharide (LPS)specificity of the mEot probe, the same blots were
probed with an mMCP1/JE-specific probe (see Experi- (Figure 5B) were performed. RNA obtained from mice
injected with PBS served as controls (data not shown).mental Procedures). This probe hybridizes with a dis-
tinct mRNA species from the mEot probe (Figure 5A). mEot expression was found to be inducible in heart,
spleen, kidney, intestine, and lung (Figure 5B).No significant amount of mEot mRNA was detected in
the skin (ear), testes, brain, kidney, heart, or bone mar- To identify which cell type(s) could express mEot in
different in vivo inflammatory situations as well as torow (Figure 5A). Expression of mEot mRNA was constitu-
tive in the thymus (Figure 5A), but not in the lungs (n 5 study its regulation, mEot expression was assessed in
a limited panel of unstimulated and stimulated cell lines6) or intestine (n 5 3; Figure 5A; data not shown).
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Figure 5. mEot mRNA Expression by Different Tissues and Cell
Types
(A) Northern blot of mEot cDNA with RNA from different mouse
organs. Each lane contains approximately 20 mg of total RNA. The
size of the hybridizing band is indicated and coincides with the size
of the mRNA detected in OVA-treated lung RNA. To confirm the
specificity of the 0.3 kb mEot cDNA probe, lung RNA from OVA-
treated mice was probed with a 0.65 kb MCP-1 (mJE) cDNA frag-
ment. The different hybridizing band obtained with this second
probe is shown. Lower portion of this panel shows a control hybrid-
ization of the blot with a b-actin probe.
(B) Northern blot of mEot cDNA with RNA from different mouse Figure 6. mEot Expression in Helper T Lymphocytes
organs after LPS stimulation. RNAs from the different organs were (A) mEot expression in two mouse Th2 clones (D10.64 and DAX)
isolated 90 min (a) and 3 hr (b) after LPS administration. Hybridizing and two Th1 clones (D1.1 and Dorris) assessed by RT±PCR. Clones
bands corresponding to mEot (upper) and b-actin (lower) are indi- were cultured in a 96-well plate (5000 cells/well) either without (lane
cated. 1) or with plate-bound monoclonal anti-CD3 (145-2C11) (Lederer et
(C) Expression pattern of the mEot gene in different cell lines and al., 1994) (lane 2) or phorbol myristate acetate and ionomycin (10
freshly isolated cell populations. Total RNA was isolated from IgM1 ng/ml and 1 mM, respectively) (lane 3) for 12 hr. Total RNA was
and Thy-11 splenocytes, peritoneal macrophages, the macrophage extracted and RT±PCR using primers specific for mEot and the
cell line RAW287, the endothelial cell line B-End, and the fibroblast control IL-4 and interferon-g genes was performed.
cell line NIH3T3 either (a) without stimulation, or (b) after exposure (B) mEot mRNA expression at different timepoints (from 22±73 hr)
to different stimuli (see Experimental Procedures) and amplified by during the induction of differentiation of Th0 lymphocytes by IL-4
RT±PCR. and IL-12. Naive T cell receptor transgenic CD41 T cells were stimu-
lated with antigen, antigen-presenting cells, and either IL-12 or IL-
4, as described (Perez et al., 1995), and total RNA was extracted.
For the restimulation experiments (n 5 3), cultures were reexposed
and purified leukocyte populations using RT±PCR. We to antigen 1 week after the first treatment and PCR was performed.
did not detect significant levels of mEot mRNA in freshly (C) Comparison of mEot mRNA expression by RT±PCR in lungs
isolated and purified Thy11 or IgM1 splenocytes or in excised from wild-type and IL-4-deficient mice at different time-
points after Nb infection.unstimulated peritoneal macrophages (Figure 5C). How-
ever, after stimulation in vitro, mEot mRNA expression
was observed in all three of these populations (Figure
(data not shown) was studied by RT±PCR on the same5C). mEot expression was also found in the fibroblast
RNA samples tocontrol for cDNA input as well as quality.cell line NIH 3T3, in the brain endothelial cell line End-
2, and in the macrophage cell line RAW287 (Figure 5C).
However, this was at a very low level in comparison to Analysis of mEot Expression in Th1/Th2
the expression of other cytokines in the same cell lines CD4 T Cell Subsets In Vitro and In Vivo
(data not shown). In vitro LPS stimulation of these cell Since Th2-type CD41 T lymphocytes play a critical role
lines resulted in a significant decrease in mEot expres- in allergic inflammatory reactions (Mossmann and Coff-
sion levels (Figure 5C). The expression of two house- man, 1989), the expression of the mEot gene was stud-
ied by RT±PCR in Th1 and Th2 cells (Figures 6A, 6B).keeping genes, b-actin (Figure 5C) and b2-microglobulin
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Two Th1 clones and two Th2 clones were cultured for of the human and guinea pig homologs and with other
C±C chemokines reveals that the three Eotaxins have24 hr in the absence or presence of several polyclonal
stimuli (Figure 6, see legend). Both Th1 and Th2 T cell two unique structural characteristics, a two-residue
gap before the second proline of the putative matureclones were determined to express the mEot gene in a
comparable fashion (Figure 6A). To determine whether peptide and an identical domain of the sequence ICADP
KKKWVQD at position 83 in the amino acid sequencethe expression of the mEot gene was regulated differen-
tially during the differentiation of Th0 T lymphocytes into (Figure 2B).
Like the other Eotaxins but not the MCPs, the geneTh1 and Th2 cells, levels of mEot mRNA were studied
by RT±PCR during the Ag-driven in vitro differentiation described here contains a partial deletion of the only
N-glycosylation site in the predicted amino acid se-of naive T cells in the presence of IL-4 (Th2 differentia-
tion) or IL-12 (Th1 differentiation) (Figure 6B). Although quence (Figure 2B). Yet another common feature to the
Eotaxins is the presence of multiple ATTTA motifs inexpression of the mEot gene was variable, no significant
differences between IL-4- or IL-12-induced Th0 cells the 39 untranslated region and the conservation of the
sequences surrounding this motif (Figure 2A). Interspe-were detected, even after restimulation (Figure 6B).
To determine whether the development of a Th2-type cies comparison of the three Eotaxins and other C±C
chemokines suggests that the Eotaxin subfamilyresponse is required for the expression of the mEot gene
in vivo, mRNA expression of this gene was studied in branched off thestem MCP/RANTES/MIP very early dur-
ing the evolution and diversification of this family andthe lung 7 days after N. brasiliensis (Nb) infection of
wild-type and IL-4-deficient mice (Kopf et al., 1993). acquired very specific functions (data not shown).
The cosegregation of the mEot gene, designated asInfection of wild-type mice results in eosinophilia and
the selective expansion, activation, and differentiation Scya11, with three other chemokine genes, Scya1 (also
known as TCA-3), Scya2 (mJE), and Scya9 (MRP-2), inof Th2 cells (Street et al., 1990), which is blocked in IL-
4-deficient mice (Kopf et al., 1993). mEot expression in the Frederick interspecific backcross, is consistent with
recent reports indicating all Scya genes mapped to datethe lungs was induced after Nb infection (Figure 6C).
mEot mRNA levels were higher on days 7 and 13 of are clustered in the central region of mouse chromo-
some 11. This region of mouse chromosome 11 sharesNb infection in both wild-type and IL-4-deficient mice,
demonstrating the independence of mEot expression on a region of homology with human chromosome 17q and
it isnot surprising all Scya genes that have been mappedthe development of a Th2 response in vivo (Figure 6C).
in humans are located on chromosome 17.
Discussion
mEot Is a Powerful and Specific Eosinophil
Chemoattractant In Vitro and In VivoEosinophil migration into allergic lungs occurs in re-
sponse to molecular events that signal allergen chal- In this study, we demonstrate that mEot does not induce
the in vitro chemotaxis of lymphocytes, neutrophils, orlenge and inflammation. To study such molecular sig-
nals, we have developed a mouse model of lung monocytes/macrophages, but is a very potent inducer
of eosinophil migration (Figures 3A, 3B). The results ofeosinophilia based on the repeated exposure of mice
to aerosolized OVA. This model has been used as a tool our in vitro transmigration assays also show that mast
cells do not transmigrate in response to mEot (data notto identify C±C chemokine genes expressed at stages
of massive pulmonary eosinophil infiltration. In this re- shown).
mEot recombinant protein is also able to elicit the inport, we describe the identification and cloning of one
mouse C±C chemokine that has 68% amino acid identity vivo recruitment of eosinophils as shown by the dose-
dependent, specific, rapid, and transient increase ofwith guinea pig Eotaxin and provide evidence that the
recombinant protein encoded by this gene displays po- eosinophils in peritoneal exudate after intraperitoneal
injection of tissue culture supernatant containing mEottent and specific chemotactic activity for eosinophils in
vivo and in vitro. We also report that the mRNA induction protein or bacterial rmEot. (Figure 3C; data not shown).
To confirm theeosinophil specificity of this gene productof this mouse chemokine gene parallels the kinetics of
eosinophil accumulation in the lung during experimen- in a model more physiologically related to asthma, mEot
was delivered into the lung of naive mice via catheteriza-tally induced eosinophilia, determine that type I alveolar
epithelial cells express the mRNA for this chemokine, tion. This series of experiments confirmed the ability of
mEot to induce a rapid and substantial accumulation ofand show that expression of this gene is not restricted
to a Th2-type response, in vivo and in vitro. eosinophils in BAL fluid (Table 2).
mEot mRNA Expression, which ParallelsSequence Comparison of mEot with Its Human
and Guinea Pig Homologs Reveals Specific the Infiltration of Eosinophils during
Experimentally Induced Lung EosinophiliaFeatures in this Subgroup of C±C Chemokines
The mouse cDNA and its predicted protein, which are In Vivo, Is Found Predominantly in Type I
Alveolar Epithelial Cells, but Can Alsodescribed here, show considerable identity with the
products of the guinea pig and human Eotaxin genes Occur in a Regulated Fashion in
Several Other Cell Types and Tissues(Figures 2A, 2B). None of the known mouse C±C chemo-
kines show more than 50% amino acid identity with mEot mRNA is not constitutively expressed in the lungs
of 6- to 15-week-old specific pathogen-free±housedmEot (Table1). Comparison of different sequence motifs
within the predicted mEot protein sequence with those healthy C57BL/6J or BALB/C mice (Figures 4A, 4 B).
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This finding differs from what was reported in guinea The physiological relevance of the strong constitutive
pigs by Rothenberg and coworkers (Rothenberg et al., expression of mEot in the thymus (Figure 5A) and the
1995a). The variable expression of gpEot mRNA in the cell types producing mEot in this lymphoid organ are
lungs of guinea pigs might reflect variable airway inflam- currently being investigated and will be described else-
mation in some individuals within a guinea pig colony where.
or interspecies physiological differences. An interesting
feature of mEot mRNA expression is that its kinetics of
induction during OVA challenge parallels that of eosino- The mRNA Expression of mEot Is Not
phil infiltration into the tissue and BAL of mice (Figures Restricted to the Development of a Th2-Type
1A, 4A, 4B). The mEot mRNA induction in response to Response In Vitro or In Vivo
OVA challenge and the accumulation of eosinophils in It is well established that distinct Th1 and Th2 subsets
BAL and tissue are transient (Figures 1A, 4A, 4B). Fur- of T lymphocytes may be distinguished on the basis of
thermore, it lasts only a few hours after the maximum the cytokine profile produced in response to antigenic
level of RNA and protein expression has been reached. stimulation (Mossmann and Coffman, 1989). Allergic in-
Our results suggest that at least at the timepoint of flammation has been shown to be associated with the
maximum eosinophilia and mEot mRNA induction, the development of a Th2 response (Fiorentino et al., 1989;
main producersof mEot mRNA are type I alveolar epithe- Mossmann and Coffman, 1989). Given that eosinophils
lial cells (Figures 4C, 4D). However, it is conceivable that are a central player in allergic inflammatory processes,
different cell types are responsible for mEot production we hypothesized that the expression of mEot could ei-
at different times during the allergic inflammatory pro- ther be assigned to Th2 CD4 T lymphocytes or predomi-
cess. This possibility is supported by the detection of nantly associated with the development of a Th2-type
mEot mRNA expression in CD41 T lymphocytes as well response. However, our results show unequivocally that
as in endothelial, fibroblast, and macrophage cell lines both Th1 and Th2 T cell clones are able to produce
(Figure 5). similar levels of mEot mRNA (Figure 6A). Our experi-
Increased numbers of mast cells are frequently pres- ments also reveal that during the in vitro differentiation
ent at sites of inflammation that contain elevated num- of Th0-type T lymphocytes, the mRNA expression for the
bers of eosinophils (Gordon and Galli, 1990). Our experi- mEot gene does not become restricted to T lymphocytes
ments indicate that primary cultures of mast cells or that differentiate along the Th2 pathway (Figure 6B).
mouse mast cell lines do not express mEot mRNA either Since the expression of some cytokines only becomes
before or after immunologic activation with IgE and anti- clearly restricted to one or other cell subset after further
gen and that they do not migrate in response to mEot restimulation, we assessed mEot mRNA expression
in vitro (data not shown). Also, low levels of mEot mRNA after restimulation. It remained equally abundant in Th1-
have been found by others in the intestine, skin, skeletal as well as in Th2-type cultures (Figure 6B). These find-
muscle mammary gland, and lymph nodes (Rothenberg ings were further confirmed in an in vivo experimental
et al., 1995b). We report here the absence of constitutive situation in which the Th2 reponse is impaired.
mEot mRNA expression in the intestine (Figure 5A). This IL-4-deficient mice do not develop a Th2 response after
discrepancy is probably due to mouse strain differences Nb infection (Kopf et al., 1993). In these mutant mice, Nb-
or due to minor differences in the health status of the induced lung eosinophilia and IL-5 levels are reduced
different mouse colonies. 70%±90% compared with wild-type mice, but mEot
A number of mechanisms could be involved in the mRNA expression levels in their lungs are comparable to
induction of mEot mRNA expression in different tissues those found in wild-type controls that develop a marked
and cell lineages. LPS is a strong in vivo inducer of mEot
eosinophilia (data not shown; Figure 6C). This result
mRNA expression in our experiments (Figure 5B). In
suggests that the expression of mEot is not sufficient
fact, mEot mRNA is strongly induced rapidly after LPS
for the development of lung eosinophilia in this model.
challenge in almost every organ studied (90 min). The
However, a definitive answer to this issue requires thestrong and fast (60±90 min) up-regulation of mEot mRNA
development of ªloss of eotaxin functionº mutant miceafter LPS challenge in vivo resembles the rapid tumor
or the usage of monoclonal antibodies that neutralizenecrosis factor or IL-1 mRNA induction in macrophages
eotaxin function in vivo. Both approaches are ongoingafter LPS injection (Lehmann et al., 1987). In vitro induc-
in our laboratory. Allergic reactions such as those intion of mEot mRNA in T and B splenic lymphocytes
response to aerosolized OVA are typical Th2-type re-and in peritoneal macrophages indicates that during an
sponses, but the mRNA induction of mEot is indepen-inflammatory response mEot mRNA can be produced
dent from the establishment of a Th2 response, asby these cells. Our experiments showed that LPS stimu-
shown by the results obtained in IL-4-deficient mice.lation of established macrophage, fibroblast, and endo-
In this situation, it is unlikely that only Th1 T cells arethelial cell lines resulted in the down-regulation of mEot
responsible for the regulated production of mEot mRNA,mRNA expression (Figure 5C). LPS has been reported
because basically noTh1-type cytokines are detected into both induce (Yoshimura et al., 1989) and repress (Col-
the BAL of OVA-treated mice (data not shown).However,otta et al., 1992; Rollins et al., 1988) MCP-1 expression.
the notion that T lymphocytes play an important role inThe molecular basis for these differences is not known,
the development of eosinophilia in this model is sup-but it has been proposed that, depending on the activa-
ported by the kinetics of their infiltration into the lung,tion state of the cell type examined, the down-regulation
which parallels that of eosinophils and by the observa-of the chemokine might represent a manner of limiting
inflammatory injury in vivo (Minty et al., 1993). tion that lymphocyte-deficient RAG1 mice have greatly
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stained with Wright±Giemsa (Fisher Diagnostics, Pittsburgh, Penn-reduced lung eosinophil infiltration in response to OVA
sylvania). Percentage of eosinophils was determined by counting(J. A. G., unpublished data).
in eight high power fields (magnification, 403; total area, 0.5 mm2)
per area selected by the same criteria as above and dividing this
Experimental Procedures number by the total number of cells per high power field. To obtain
the absolute number of eosinophils in the lavage, this percentage
was multiplied by the total number of cells recovered in the lavageMice and In Vivo Experimental Procedures
fluids.Male and and female 8- to 10-week-old BALB/C and C57BL/6J mice
were purchased from the Jackson Laboratory (Bar Harbor, Maine)
and kept in the Center for Blood Research Specific Pathogen-Free
PCR Cloningmouse facility. These mice were used for the generation of pulmo-
Total RNA from eosinophilic lungs of OVA-sensitized and PBS-nary eosinophilia in response to OVA (Sigma, St. Louis, Missouri)
treated control mice (day 21, 3 hr after treatment) was extractedand for functional assays in vivo with mEot recombinant protein.
following the guanidinium thiocyanate method (Chomczynski andFor the induction of a pulmonary inflammatory response (Figure 1A,
Sacchi, 1987). Of this RNA, 1 mg was used as substrate for oligoscheme), mice (four individual experiments, n 5 25) were sensitized
d(T) primed RT (Larrick, 1992). Of the RT products, 1 ml was thenby intraperitoneal injection of OVA (0.1 mg in 400 ml of PBS per
used as template for PCR amplification on a DNA Thermal Cyclermouse) on day 1 of treatment. On day 8 and daily from days 15±21,
480 (Perkin-Elmer Cetus; 30 cycles at 948C for 30 s, 458C for 120 s,animals were challenged by exposure to aerosolized OVA (2% OVA
728C for 30 s, and 20 cycles at 948C for 30 s, 558C for 30 s,for 5 min on day 8 and 1% OVA for 20 min on days 15±21) using a
and 728C for 60 s) with two degenerate oligonucleotide primersWhisper Jet Nebulizer system (MMP, Englewood, Colorado). Aero-
1, (AAGATC(TA)(CG)(TC)TT(CT)CAGCG(CG)CTGAAG(TA)(CG)(TC)Tsolized PBS was administered to mice as a negative control (four
ACT) (x-256 degeneracy) and 2, (GGCGTCCTGCACCCACTTCTCCTindividual experiments, n 5 10). At various intervals after aerosolized
TGGGGTCGGC) corresponding to conserved regions in the se-OVA administration, mice were euthanized by barbiturate overdose
quences of gpEot and human members of the MCP family. PCRand analyzed. Functional assays were performed by intraperitoneal
products (150 bp) products were cloned into PCR II Vector (In-injection of mEot recombinant protein (12.5 U or 62.5 U of mEot
vitrogen, San Diego, California). Clones were organized into threerecombinant protein in 100 ml or 500 ml). After injection (0, 1, 2, 3,
groups on the basis of the relative homology of their sequence toor 4 hr), a peritoneal lavage with 10 ml of PBS was performed
gpEot and human MCP-3.and recovered cells analyzed as described below (three individual
To clone the full-length mEot cDNA, a two-step PCR amplificationexperiments, n 5 3 for test and control mice per timepoint and
strategy was utilized. In the first step, 59 RACE (Frohman et al., 1988)dose). mEot recombinant protein was also administered to anesthe-
with degenerate primers designed from conserved sequences intized mice (0.4 mg Rompun 20:2 mg Ketaset per mousein a subcuta-
the fragments of C±C chemokines obtained above under conditionsneous injection; Hogan et al., 1985) via a small catheter cannulized
of low stringency was used to amplify various 59 clones from totalthrough an endotracheal tube inserted into the right lung. For these
RNA of eosinophilic lungs. The second step, isolation of the full-experiments, 12.5 U of recombinant mEot protein or an equivalent
length cDNA, involved PCR amplification with specific primers de-volume of control tissue culture supernatant (100 ml) were delivered.
signed from the 59 clones generated in step 1. Total RNA fromMice were kept under anesthesia and 0, 1, 2, or 3 hr later a BAL
eosinophilic lungs was reverse transcribed, as recommended bywas performed and analyzed as described below (n 5 2 per time-
the SuperScript II supplier (GIBCO BRL), using 1 pmol of primer 2.point). Total RNA was also extracted from lungs excised from OVA-
The cDNA was subsequently poly(A) tailed and used as templatetreated and control mice (n 5 2 lungs per timepoint) and from several
for PCR with primers 2 and 3 (a chimeric primer containing [dT]17organs 90 min and 3 hr after intravenous injection of LPS (50 mg
and sequence of the T7 promoter: 59-TAATACGACTCACTATAGGGLPS in 200 ml of PBS per mouse) or PBS (n 5 2 per timepoint and
ATTTTTTTTTTTTTTTTT), annealing at 458C for 2 min and extendingtreatment).
at 728C for 10 min. Once sufficient amplification products with theTo obtain mouse eosinophils, IL-5 transgenic mice (Tominaga et
poly(A) and T7 sequences were generated from extension of primeral., 1991) were injected with cadmium sulfate (2 mg/Kg; Sigma).
2, further amplification was carried out over 40 cycles (948C for 30Mice were retraorbitally bled 4 days later, under anesthesia, 30 min
s; 508C for 25 s; 728C for 1 min). A second round of amplificationafter intraperitoneal injection of 200 U of heparin.
For the Nb infection, IL-4-deficient (Kopf et al., 1993) and 129Sv was then performed as described above, using the specific primers
wild-type littermate mice (n 5 9) were infected subcutaneously with 4 (sequence of the T7 promoter: 59-TAATACGACTCACTATAG GG)
750 Nb third-stage larvae (L3) at day 0 as previously described and5 (designednested to 2 from the sequence of the 150bp putative
(Jennings et al., 1963). Lungs were removed and pooled (n 5 3) at mEot partial fragment: 59-CAGATCTCTTTGCCCAACCT) and 1 ml of
days 4, 7, and 13 of infection. the first-round PCR products as template. Sequence analysis of
PCR products showed that the cloned 59 fragment had significant
homology to gpEot and allowed the construction of primers thatQuantitation of Eosinophils in Lung Sections
could be used to clone the full mEot cDNA. From this PCR fragment,and Lavage Fluids
a 0.3 kb mEot coding region probe was generated for later use inLungs from OVA-treated mice were fixed in 10% formalin, embed-
Southern, Northern, and whole-mount in situ analysis (shown inded in paraffin (Tissue-Tek, Miles, Incorporated, Somerset, Massa-
Figure 2A). This probe was usedbecause it lacks the mostconservedchusetts), sectioned at 5 mm (Reichert±Jung microtome), and
domains of C±C chemokines and therefore has lower percent iden-stained with hematoxylin and eosin (H and E) by sequential immer-
tity with the sequences of other mouse C±C chemokines.sion in hematoxylin (Gill's double strength) for 2 min, Scott buffer
In the second step, the full-length mEot cDNA was also obtained(0.2% sodium bicarbonate, 1% magnesium sulfate in tap water) for
through two rounds of amplification. In round 1, 1 ml of RT products2 min, eosin Y (1% aqueous) for 3 min, and azure II (0.1% aqueous)
generated using primer 3 was used as template for PCR amplifica-for 1 min. After each step, sections werewashed in H2O. Background
tion using primers 3 and 6 (designed from the 59 sequence of thedecolorization was done in ethylene glycolmonomethyl ether (Sigma
0.3 kb putative mEot fragment: 59-AGAGGCTGAGATCCAAGCAG).Chemical Company, St. Louis, Missouri) for 15 s. Sections were then
In round 2, products from the first round were used as template forair dried and mounted in Permount (Fisher Scientific). Perivascular
amplification of further specificity using primers 4 and 7 (a primerand parenchymal eosinophil infiltration was examined. Number of
containing sequences nested to 6: 59-TCTCCCTCCACCATGCeosinophils was determined for four high power fields (magnifica-
AGAG).tion, 403; total area, 0.5 mm2) per section and area. These high
power fields were selected randomly under a low power of magnifi-
cation (43) at which eosinophils were not visible and compared with
Southern and Northern Blotsthe number of eosinophils present in control mice.
Mouse genomic DNA (10 mg) was digested with HindIII or BamHITo determine the number of eosinophils in lavage fluids, 5 3 105
lavage cells were applied to glass slides by cytocentrifugation and (New England Biolabs. Beverly, Massachusetts), electrophoresed
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in a 0.8% agarose gel and transferred to a nylon membrane (Genes- with concanavalin A (5 mg/ml) and LPS (20 mg/ml) (Sigma, St. Louis,
Missouri), respectively, for 90 min.creen, Dupont), and hybridized with a 32P-labeled 0.3 kb mEot cDNA
PCR fragment as described (Maniatis et al., 1982). Eosinophils were purified from the blood and from the spleen of
cadmium-treated IL-5 transgenic mice (Tominaga et al., 1991) usingC57BL/6J HindIII-digested genomic DNA was probed with the
mEot probe of above or with a 0.65 kb MCP-1/JE cDNA probe as immunomagnetic depletion of lymphocytes (which are 80%±90%
of the noneosinophilic leukocytes in these organs; G.-Q. J., unpub-a control of the specificity of the fragment. The different restriction
band patterns obtained in these blots clearly demonstrate that the lished data). In brief, erythrocyte-lysed blood and spleen cells were
labeled with biotin-conjugated anti-Thy1 (53.2.1) and anti-B220mEot probe is specific and does not cross-react with at least the
mMCP-1/JE gene (data not shown). (6B2) and treated with streptavidin-coated magnetic beads (m450,
Dynal). Eosinophils were enriched by negative selection through aNorthern blots (Sambrook et al., 1989) were performed with 20 mg
of total RNA from indicated tissues fractionated in a 1.5% agarose/ magnetic field. The resulting preparations were 85%±95% eosino-
phils. Macrophages and neutrophils were obtained from the boneformaldehyde gel and blotted onto a nylon membrane (Genescreen,
marrow and peritoneum after injection of thyoglicolate and percollDuPont). Hybridization and washing were performed as recom-
gradient separation (Luo et al., 1994). Lymphocytes were obtainedmended by the supplier. Blots were also hybridized with an 0.65 kb
from the spleen and lymph nodes after immunomagnetic depletionmMCP-1/JE-specific probe generated by EcoRI cleavage of the
of Mac-11 cells as explained above.mMCP-1/JE cDNA.
Mouse bone marrow mast cells were obtained by culturing bone
marrow cells from the femurs and tibias of 6- to 16-week-old BALB/
Interspecific Mouse Backcross Mapping C mice for 3±8 weeks in the presence of 50% WEHI-3 (American
Interspecific backcross progeny were generated by mating (C57BL/
Tissue Culture Collection, Rockville, Maryland) cell-conditioned me-
6J 3 Mus spretus)F1 females and C57BL/6J males as described
dium and 50% enriched medium as described (Razin et al., 1984).
(Copeland and Jenkins, 1991). A total of 205 N2 mice were used to After 3 weeks, >96% of the nonadherent cells in culture were mast
map the Scya11 locus. cells, as assessed by metachromatic staining with toluidine blue.
A description of the probes and RFLPs for the loci linked to Cells were cultured for z18 hr in 50 ng/ml recombinant stem cell
Scya11, including neurofibromatosis type 1 (Nf1), small inducible factor and 20 U/ml recombinant IL-10 before use. The MC4W mast
cytokines a1, a2, and a9 (Scya1, Scya 2, and Scya 9, respectively ) cell line that had been transfected with the pMH±neo plasmid vector
and myeloperoxidase has been reported previously (Youn et al., was maintained in 5% WEHI-3 cell-conditioned medium (Fruman et
1996). al., 1995). Cells were activated with IgE and antigen as described
(Fruman et al., 1995).
The macrophage cell line RAW287 was cultured with tumor necro-Measurement of mEot mRNA Expression by RT±PCR
sis factor-a (20 ng/ml) for 24 hr and the endothelial cell line bEnd3Total RNAwas isolated using the guanidinium thiocyanate/acid phe-
and the fibroblast cell line NIH 3T3 were cultured with phorbol myris-nol procedure (Chomczynski and Sacchi, 1987). Nb-infected lungs
tate acetate/ionomycin (10 ng/ml per 500 ng/ml) for 8 hr. Two mouse(3) were pooled per timepoint for RNA extraction. To obtain mRNA
Th2 clones (D10.64 and DAX) and two Th1 clones (D1.1 and Dorris)from Th1 and Th2 cell clones and for the Th0 in vitro differentiation
were stimulated in a 96-well plate (5000 cells/well) with either plate-cultures, 5000 cells were cultured in 96-well plates and subjected
bound monoclonal anti-CD3 (1452C11) (Lederer et al., 1994) or phor-to four different stimuli. Cells were harvested by brief centrifugation
bol myristate acetate and ionomycin (10 ng/ml and 1 mM, respec-and lysed directly in the well by addition of 20 ml of guanidinium
tively) for 12 hr. For in vitro Th0 differentiation to Th1 and Th2 cells,thiocyanate lysis solution and vigorous vortexing. RNA was isolated
naive T cell receptor transgenic CD41 T cells were stimulated inby magnetic beads linked to oligo(dT)20, as recommended by the
vitro in a 96-well plate (5000 cells/well) with antigen, antigen-pre-supplier (PerSeptive Diagnostics, Incorporated, Cambridge, Massa-
senting cells, and either IL-12 or IL-4, respectively, as describedchusetts). The same procedure was used to obtain RNA from sorted
(Perez et al., 1995) and analyzed for their mEot expression levelsCD31 and IgM1 splenic populations.
by RT±PCR. mEot expression in these primed T cells after furtherFor RT±PCR, first-strand cDNAs from 1 mg of total RNA were
restimulation was also studied. For these experiments, the cellsgenerated by reverse transcription with a random hexamer in 20 ml.
were restimulated in microculture with mitomycin C-treated spleno-Of the RT products, 1 ml was then used as the template for PCR
cytes for 2 days and analyzed.amplification using mEot-specific primers 5 and 6 (described above
and in Figure 2A) for 32 or 35 cycles by a step program (948C for
Production of Recombinant mEot Protein30 s; 568C for 25 s; 728C for 30 s) on a thermal cycler. Total products
in p3X63 Myeloma Cellswere loaded in a 1.5% agarose gel where mEot resolves as a 0.3
A fragment of the mEot cDNA containing the entire coding sequencekb fragment. To confirm whether the primers used in RT±PCR mea-
(from 30±530 in the nucleotide sequence; Figure 2A) was clonedsurements are specific for mEot, PCR products from the lung and
into the expression vector pEFpuro in the sense orientation (Mizu-thymus were cloned and sequenced as described in the section for
shima and Nagata, 1990). p3X63 myeloma cells (Karasuyama andPCR cloning. The b-actin message was amplified and titrated using
Melchers, 1988) (1 3 107) were transfected with 20 mg of linearizedspecific primers and the same RT products to normalize for amount
plasmid DNA by electroporation using a BioRad gene Pulser appara-of input cDNA (Jia and Gutierrez-Ramos, 1995). Although not shown,
tus (BioRad), as recommended by the manufacturer. Transfectedmost samples were also standardized for the expression of S12 and
cells were selected 2 days after electroporation by puromycin resis-HPRT genes using specific primers as previously described (Svetic
tance at a concentration of 6 mg/ml for 2 weeks. Cells were culturedet al., 1993). The same amplification without RT template in each
in the selection medium with 10% fetal calf serum and subsequentlyreaction was performed as a negative PCR control. As a negative
grown for several days in serum-freemedia. Serum-free supernatantand positive control for mEot expression at the different gestational
from the cultures of transfected cells was used for the transwellages, unstimulated and LPS-stimulated spleen were used, respec-
chemotaxis assay and for the in vivo induction of eosinophil accu-tively. IL-2 or interferon-g and IL-4 mRNAs assayed by the same
mulation. A construct containing the same fragment of cDNA in themethod were used as positive controls to confirm the phenotype
pEFpuro expression vector, but in the antisense orientation, wasof Th1 and Th2 cells, respectively.
also transfected into pX63 cells to generate thecontrol tissue culture
supernatant. Bacterial rmEot protein was obtained from Prepotech,
Cell Lines and Freshly Isolated Populations Incorporated. The recombinant protein was purified by HPLC or ion-
To obtain purified CD31 and IgM1 splenocytes, these splenic cell exchange chromatography. Endotoxin levels were estimated less
populations were sorted by FACS resulting in >97% purity using than 0.1 ng per mg (or 75 U) of Eotaxin as assessed by the LAL
phycoerythrin-conjugated monoclonal antibody directed against assay (BioWhittaker, Maryland).
Thy1.2 (53±2.1) (PharMingen) and fluorescein isothiocyanate±
conjugated IgM from (Southern Biotechnology). Cell sorting was In Vitro Chemotaxis and In Vivo Recruitment Assays
performed on an ELITE cell sorter (Coulter Electronic, Hialeah, Flor- The in vitro migration of leukocytes to recombinant mEot was evalu-
ated, in duplicate, using a 24-well chemotaxis chamber (Rot et al.,ida). CD31 and IgM1 purified splenocytes were stimulated in vitro
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1992) in which various dilutions of tissue culture medium containing with asthma: comparison with biopsy specimens from atopic sub-
jects without asthma and normal control subjects and relationshipmEot recombinant protein in a final volume of 600 ml were added.
Transwells with 5 mm pores were inserted into each well and 2 3 to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 88,
661±670.105 cells in 100 ml of IMDM medium added to the top chamber.
Assay plates were incubated for 1 hr at 378C in 5% CO2. After 1 hr Briscoe, D.M., Cotran, R.S., and Pober, J.S. (1992). Effects of tumor
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1 by human mononuclear monocytes. J. Immunol. 148, 760±765.supernatant into the peritoneum or by direct delivery into the lung
of mice as described in the in vivo experimental procedures. At Conlon, R.A., and Rossant, J. (1992). Exogenous retinoic acid rapidly
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Whole-Mount ISH Saunders Company).
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The accession number for the mouse eotaxin cDNA sequence re-
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Note Added in Proof
During the preparation of this manuscript, the receptor for eotaxin
on human and mouse eosinophils has been cloned and identified
as CKR-3 (C. Mackay, personal communication; J.-C. G.-R. and C.
Gerard, in preparation).
